Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 9 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              227.67              200.05           303.00    
                   (+13.8 pct)         (-6.6 pct)       (+13.0 pct) 
  Operating           23.12                7.13            23.50    
                  (+224.2 pct)         (-65.8 pct)     (+118.7 pct) 
  Recurring           29.17               11.49            29.50    
                  (+153.8 pct)         (-53.5 pct)      (+60.2 pct) 
  Net                 20.90                8.97            19.00    
                  (+132.9 pct)         (-37.0 pct)      (+44.8 pct) 
  EPS              254.93 yen          110.43 yen       231.76 yen  
  EPS Diluted      254.60 yen          110.30 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news